Literature DB >> 17157156

Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.

Alissa Huston, Jason Brown, G David Roodman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157156     DOI: 10.1016/j.exphem.2006.07.010

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


× No keyword cloud information.
  2 in total

1.  Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma.

Authors:  R Khan; S Apewokin; M Grazziutti; S Yaccoby; J Epstein; F van Rhee; A Rosenthal; S Waheed; S Usmani; S Atrash; S Kumar; A Hoering; J Crowley; J D Shaughnessy; B Barlogie
Journal:  Leukemia       Date:  2012-02-02       Impact factor: 11.528

2.  Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States.

Authors:  Yi Qian; Debajyoti Bhowmik; Christopher Bond; Steven Wang; Sam Colman; Rohini K Hernandez; Paul Cheng; Michele Intorcia
Journal:  Cancer Med       Date:  2017-06-14       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.